Doxazosin Tablet
Product Images NDC 84677-044

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 84677-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

84677-044-01ol- Doxazosin Tablet 1mg 100ct.jpg (84677 044 01ol Doxazosin Tablet 1mg 100ct)

Doxazosin Tablets, USP 1 mg oral tablets label by Golden State Medical Supply, Inc. The label displays the NDC number 84677-044-01 and indicates a package size of 100 tablets for prescription use only. It includes storage instructions, dispensing guidelines, and marketing information from GSMS, Incorporated.*

FDA Label Image

84677-045-01ol- Doxazosin Tablet 2mg 100ct.jpg (84677 045 01ol Doxazosin Tablet 2mg 100ct)

Doxazosin Tablets USP 2 mg oral dosage form label from Golden State Medical Supply, Inc. The label indicates 100 tablets per container, with pharmacy instructions advising dispensing patient information. It includes storage and handling instructions, dosage information, and a barcode, emphasizing keeping the medication out of reach of children.*

FDA Label Image

84677-046-01ol- Doxazosin Tablet 4mg 100ct.jpg (84677 046 01ol Doxazosin Tablet 4mg 100ct)

Doxazosin 4 mg tablets, USP oral dosage form, labeled by Golden State Medical Supply, Inc. The label includes NDC 84677-046-01 and indicates a bottle containing 100 tablets for prescription use only. The label provides storage instructions and dosing cautions.*

FDA Label Image

84677-047-01ol- Doxazosin Tablet 8mg 100ct.jpg (84677 047 01ol Doxazosin Tablet 8mg 100ct)

Doxazosin 8 mg tablets, USP label from Golden State Medical Supply, Inc. The label includes the NDC number 84677-047-01 and specifies a bottle containing 100 oral tablets. It features dosing and storage instructions, barcode, and lot and expiration date placeholders, with a note for pharmacists to dispense patient information.*

FDA Label Image

Structure (C2bacf15 E521 4d06 B4c6 45b40036b73c 01)

Chemical structure of Doxazosin, depicting its molecular components including fused aromatic rings, heterocyclic elements, and sulfonic acid moiety.*

FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 02)

A chart and table presenting clinical study results comparing placebo and doxazosin (4 mg and 8 mg) on symptom scores and maximum urinary flow rate (mL/sec) in patients. The table shows baseline means and mean changes for symptom scores and flow rates across three studies, while the bar chart illustrates symptom score and maximum flow rate changes in Study 2, highlighting statistically significant improvements with doxazosin doses versus placebo.*

FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 03)

Two line charts depicting clinical study results for Doxazosin 8 mg compared to placebo over 14 weeks. The left chart shows mean change in total symptom score from baseline, with Doxazosin reducing symptoms more than placebo. The right chart shows mean increase in maximum urinary flow rate (mL/sec), with Doxazosin significantly improving flow compared to placebo.*

FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 04)

FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.